Indofood Sukses Makmur Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Indofood Sukses Makmur Tbk. trades at Rp6,750 (market cap 59.27T, 4.84M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Indofood Sukses Makmur Tbk. is far larger — about 5.2× Tempo Scan Pacific Tbk.'s market cap, and Indofood Sukses Makmur Tbk. is more actively traded (4.84M versus 1.77M). Which is the better fit depends on your goals.
| INDF | TSPC | |
|---|---|---|
Market Cap | 59.27T | 11.36T |
Volume | 4.84M | 1.77M |
Lot | 48.4K | 17.71K |
Turnover | 32.59B | 4.61B |
Average Price | 6,733.07 | 2,603.9 |
Value | 32.59B | 4.61B |
Indicative Equilibrium Price | 6,750 | 2,590 |
Indicative Equilibrium Volume | 8.72K | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indofood Sukses Makmur Tbk was established on August 14, 1990 under its original name PT Panganjaya Intikusuma. The Ministry of Justice in its decision letter dated July 12, 1991 approved the deed of establishment. The company’s articles of association has been amended from time to time, the latest of which was covered by notarial deed No. 149 of the same notary dated June 24, 1997 concerning, among others, the increase in the company’s authorized capital stock, the change in the company’s name from PT Indofood Sukses Makmur to PT Indofood Sukses Makmur Tbk, and the change in the company’s corporate life from limited to unlimited period. The Company started its commercial operations in 1990. The company’s shares are listed in the Jakarta and Surabaya Stock Exchanges.
Read more on INDF →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →